SUTUREGARD® ISR & HEMIGARD™ Devices | Press Release | SUTUREGARD

SUTUREGARD® Medical, Inc. Blog

 
07Feb

Press Release - Newly published research in the Journal of Clinical Biomechanics supports using novel devices, such as the SUTUREGARD® ISR Retention Suture Device and the HEMIGARD™ Adhesive Retention Suture Device, to initiate approximation of high-tension surgical wounds.

Newly published research in the Journal of Clinical Biomechanics supports using novel devices, such as the SUTUREGARD® ISR Retention Suture Device and the HEMIGARD™ Adhesive Retention Suture Device, to initiate approximation of high-tension surgical wounds.

In the latest issue of the Journal of Clinical Biomechanics, the study “Forces on sutures when closing excisional wounds using the rules of halves”, led by Professor Jay Kruzic, of the University of New South Wales School of Mechanical and Manufacturing Engineering, demonstrated that the average force to close the mid-point of elliptical excisional wounds is, at least, six times more than subsequent closing force of the remainder of the wound when closing linearly.

This prospective, single-center, IRB-approved study evaluated the mid-point force to approximate wound edges with nonabsorbable suture in 18 patients. The average force to close the center of the wounds was six times larger than that of the second and third sutures, which was a statistically significant finding (p <.001). Forces to close the bisected halves were essentially negligible.

This finding has important clinical implications. The authors propose that the goal of closing high tension wounds linearly occurs in two distinct phases: 1) relief of midpoint tension and 2) application of supports to maintain closure.

The SUTUREGARD® ISR Retention Suture Device and the HEMIGARD™ Adhesive Retention Suture Device allows surgeons to initiate approximation of high-tension surgical wounds with suture without damaging the skin. The devices do this by dispersing the pressure of the suture away from the wound edges.

Based in Portland, Oregon, SUTUREGARD® Medical, Inc is a private company offering novel medical devices for surgeons to repair challenging surgical defects more simply. SUTUREGARD® medical devices are intended to provide minimal wound trauma and reduce the healing period after surgery, providing better results for patients.

View Publication

 

Related

No Undermining? Are You Kidding Me?

By: Dan Ladizinsky, MD, CEO, SUTUREGARD Medical, Retired Board Certification in General Surgery, Pla...

Read More >

Bill Lear, MD, Discusses Development of HEMIGARD ARS

Bill Lear, MD, Mohs surgeon now but 5-year emergency physician previously, talks with Dr. Mark Plast...

Read More >

A New Way to Simply Close Wounds after Skin Cancer Removal: The Picture Tells the Story.

Patrick Dillon is a very active man who is often in the beautiful San Juan Mountains near his SW Col...

Read More >

SUTUREGARD® Suture Retention Bridges

Retention sutures are heavy gauge percutaneous sutures, used in high tension wound closures to suppo...

Read More >

The Future of Scar Surgery: Low Tension Healing

How many times have you done an elliptical excision, and the postoperative scar result is widened at...

Read More >

Press Release - Patient Self-Removal of HEMIGARD During COVID Now Published

JAAD Case Reports recently published, “Use of a novel adhesive suture retention wound closure devic...

Read More >

Relax & Close, More Wounds, More Simply.

Making wound closure easier for surgeons and better for patients.

Order Now